Overview

Does Clinical Response Correlate With Serum Certolizumab Levels?

Status:
Unknown status
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
A prospective open label trial of adult patients with active Crohn's disease to determine if plasma concentrations of certolizumab pegol correlate to mucosal healing.
Phase:
Phase 4
Details
Lead Sponsor:
Shafran Gastroenterology Center
Collaborator:
UCB Pharma
Treatments:
Certolizumab Pegol